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Abstract
Purpose—The aim of this study was to compare associations between generic versus diseasespecific functional health status assessments and patient and clinical characteristics for patients
with severe congenital heart disease.
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Methods—This was a cross-sectional observational study involving 325 single ventricle patients,
aged 10–18 years, after Fontan procedure. Enrolled patients underwent a medical history review,
laboratory testing, and assessment of the functional health status by completion of the generic
Child Report Child Health Questionnaire and the disease-specific Congenital Heart Adolescent
and Teenage questionnaire. Correlated conceptually equivalent domains from both questionnaires
were identified and their associations with patient and clinical variables were compared.
Results—From the generic assessment, patients perceived marginally lower physical functioning
(p = 0.05) but greater freedom from bodily pain compared with a normal population (p < .001).
The equivalent physical functioning/limitations domain of the generic instrument, compared with
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the disease-specific instrument, had similar associations (higher multi-variable model R2) with
medical history variables (R2 = 0.14 versus R2 = 0.12, respectively) and stronger associations with
exercise testing variables (R2 = 0.22 versus R2 = 0.06). Similarly, the corresponding freedom from
bodily pain/symptoms domains from both questionnaires showed a greater association for the
generic instrument with medical history variables (R2 = 0.15 versus R2 5 0.09, respectively) and
non-cardiac conditions (R2 = 0.13 versus R2 = 0.06). The associations of each questionnaire with
echocardiographic results, cardiac magnetic resonance imaging results, and serum brain natriuretic
peptide levels were uniformly weak (R2 range <.01 to 0.04).
Conclusions—Assessment of the physical functional health status using generic and diseasespecific instruments yields few differences with regard to associations between conceptually
similar domains and patient and clinical characteristics for adolescents after Fontan procedure.
Keywords
Fontan procedure; cardiac defects; congenital; paediatrics
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For patients with functional single ventricle after Fontan procedure, the suboptimal
functional health status has been variably described,1 including reports from the Fontan
cross-sectional study that was performed by the Pediatric Heart Network.2 This study
enroled 546 Fontan patients aged 6–18 years and included assessment of patient
characteristics and medical history, the functional health status, and standardised assessment
in terms of cardiopulmonary exercise testing, echocardiography, cardiac magnetic resonance
imaging, and measurement of brain natriuretic peptide levels.
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Several reports from this study have addressed issues pertaining to the functional health
status. Using the parent report form of the Child Health Questionnaire, CHQ-PF50,3 which
is a generic assessment instrument, parents scored their children worse than a normal United
States population sample in nearly all domains and reported a higher prevalence of noncardiac health problems.4 With regard to a subset of patients who were age-eligible and
completed the child report form of the Child Health Questionnaire (CHQ-CF87), their
parents reported lower scores in many domains compared with those reported by the
children themselves.5 These parent– child discrepancies were higher in the presence of
increased non-cardiac health problems in the child. An independent study has shown that
Fontan patients scored themselves lower if they had a normal sibling, perhaps indicating an
altered self-perception in the presence of a constant normal comparison.6
Disease-specific assessment has been advocated as a more specific and responsive measure
of the functional health status for a given disease condition and differs from generic
assessment both conceptually and qualitatively. Disease-specific instruments often have
different domains that are specific to the disease condition, such as impact of particular
symptoms, morbidities, and treatments. In addition, although some domains and items may
be similar to those measured by generic instruments, the attribution of the effect is specific
to the disease condition. For example, an item from generic instruments might ask, “How
often do you experience pain or physical limitation in your daily activities?” A diseasespecific instrument, in contrast, might add the qualifier “due to your heart condition”.
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We sought to determine the relationships between equivalent conceptual domains from the
patient-completed generic Child Health Questionnaire and a patient-completed congenital
heart disease-specific instrument, the Congenital Heart Adolescent and Teenage
questionnaire,7,8 administered to Fontan patients aged 10–18 years as part of the Fontan
cross-sectional Study. We also sought to determine the magnitude of associations of the
identified equivalent physical functioning domains from each questionnaire with regard to
patient and medical characteristics and laboratory measures. We hypothesised that the
congenital heart disease-specific measure would show stronger associations with medical
and laboratory testing characteristics.

Patients and methods
Study design and patients
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The Fontan cross-sectional study was performed by the Pediatric Heart Network;9 the design
and methods have previously been described.2 Written informed consent or assent was
obtained from all participants as approved by the institutional review committees at each of
the seven North American institutions. Patients aged 6–18 years at enrolment and who
underwent a Fontan procedure 6 months or earlier were included. Patients were excluded if
they had important non-cardiac or psychiatric conditions precluding or influencing testing,
were pregnant or were planning to conceive, were presently participating or were planning
to participate in another conflicting research study, or had a primary caregiver who lacked
reading fluency in both English and Spanish. All study testing was to be completed within 3
months of enrolment and included medical record abstraction, completion of questionnaires,
measurement of serum brain natriuretic hormone levels, echocardiography, cardiopulmonary
exercise testing, and cardiac magnetic resonance imaging.
Functional health status questionnaires
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The Child Health Questionnaire was used as a generic measure of the functional health
status. Only patients aged 10 years and above who had completed the child report version
(CHQ-CF87)3 were included in the present analyses. The Child Health Questionnaire
assesses the functional health status in 10 scale domains of physical, behavioural, emotional,
social, and family well-being and four categorical single item domains. The domain scores
range from 0 to 100, with higher scores indicating better function, and distributions tend to
be upwardly skewed, with relevant ceiling effects. The instrument has been validated for use
in children and adolescents aged between 10 and 18 years. Patients also completed the
Congenital Heart Adolescent and Teenage questionnaire as a disease-specific measure of the
functional health status. The development, properties, and initial validation of this
questionnaire have previously been described.7,8 The Congenital Heart Adolescent and
Teenage questionnaire includes five scale domains on physical, emotional, and social wellbeing and three categorical single item domains. Scale domains range from 0 to 100, and
single item domains range from 0 to 5, with higher values indicating worse functioning, with
similarly skewed distributions and relevant ceiling effects. The questionnaire items probe for
deficits and impacts specific to the patient’s perception of their heart problem.
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Medical history and laboratory testing

NIH-PA Author Manuscript

A detailed medical record review was performed for all study participants. Details on the
laboratory testing procedures and variable selection for analysis of the associations with the
functional health status have been reported elsewhere.2,4,10
Data analysis
Data are described as frequencies, medians with 25th and 75th percentile values, and means
with standard deviations as appropriate. Given the skewed distribution of brain natriuretic
peptide values, a normalising logarithmic transformation was used. The study population
used for analysis was restricted to 325 patients aged 10–18 years who completed both
questionnaires. As all laboratory tests were not performed in all patients, we performed
separate analyses that were restricted to each individual test data set, similar to a previously
reported analysis.10
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Domain scores from the Child Health Questionnaire were contrasted against values from a
normative population11 using single sample Wilcoxon signed-rank tests. These values were
derived from a suburban school-based normal population of 232 children aged 10–15 years
who self-completed the questionnaire in 1995. The distributions of domain scores for both
questionnaires were highly skewed, and preference was given to using ranks and nonparametric statistical methods for analysis. To determine which conceptually equivalent
domains from the two questionnaires to use in comparisons of associations with medical
history and laboratory testing variables, a Spearman correlation matrix was created.
Conceptually equivalent domains with higher correlations from each questionnaire were
rank-transformed and then explored for an association with medical history and laboratory
testing variable groups in multivariable linear regression models. The R2 adjusted for the
number of included variables was determined for each variable group, and was taken to
represent the proportion of variation in the domain scores explained by all of the variables in
each group. A total of six variable groups were created: medical history, non-cardiac
conditions, echocardiography, exercise testing, magnetic resonance imaging, and serum
brain natriuretic peptide levels. Variables within each group and their values are shown in
Table 1. Variable groups for laboratory testing were used to determine the associations that
were specific to that test but also because all patients did not undergo all laboratory tests and
not all patients who underwent a particular test had key variables assessed. Imputation of
missing values was performed as previously described.4,10 Data analyses were performed
using the Statistical analysis systems statistical software version 9.2 (SAS Institute
Incorporated, Cary, North Carolina). All statistical testing was two-sided.
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Results
Study participation
Medical records were screened for 1078 patients who underwent a Fontan procedure as
identified from existing institutional databases at each Pediatric Heart Network clinical
center, with 831 patients deemed potentially eligible for participation. After being contacted,
637 patients were confirmed to be fully eligible, and informed consent as approved by each
centre was obtained for 546 (86%) patients between March 2003 and April 2004. Of these,
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354 patients were 10–18 years of age, with 329 completing the Child Health Questionnaire
and 326 completing the Congenital Heart Adolescent and Teenage questionnaire. Of the
eligible non-respondents, seven could not complete the questionnaires because of severe
physical or mental disability. The study population for the present analysis includes the 325
patients who completed both questionnaires.
Patient characteristics
The distribution of patients, medical and laboratory testing characteristics, together with
their associations with Parent Report Child Health Questionnaire Physical and Psychosocial
Functioning Summary Scores have been reported previously for all patients aged 6–18 years
completing the study – the present analysis includes only patients aged 10–18 years who
completed the child report version.4,10 Selected characteristics of the 325 patients included
in the present analysis are shown in Table 1. The mean age at enrolment was 13.9 years, and
the mean interval from Fontan procedure to enrolment was 10.3 years (range 1.8–17.3
years).
Functional health status
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Distributions of scores for both the Child Health Questionnaire and the Congenital Heart
Adolescent and Teenage questionnaire are shown in Table 2. Some data from a normal
population were available for some domains of the Child Health Questionnaire.11 Compared
with a normal population,3,11 Fontan patients scored themselves significantly lower for
physical functioning but significantly higher for freedom from physical, emotional and
behavioural limitations on roles, freedom from bodily pain, and mental health issues. The
scores from the Fontan patients were not significantly different from the normal population
for the domains of behavior problems, self-esteem and general health perceptions.
Associations between the Child Health Questionnaire and the Congenital Heart Adolescent
and Teenage questionnaire domains
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In order to identify correlated conceptually equivalent domains between the two
questionnaires for comparison on the relative strengths of their associations with medical
history and laboratory testing characteristics, a Spearman correlation matrix was developed
(Supplementary Table S1). There were significant correlations between many of the
domains from the two questionnaires. The highest correlations were between the Child
Health Questionnaire physical functioning domain and the Congenital Heart Adolescent and
Teenage questionnaire domains of symptom discomfort (r = −0.43) and activity limitations
(r = 0.58). The Child Health Questionnaire domain of freedom from bodily pain and the
Congenital Heart Adolescent and Teenage questionnaire domain of symptom discomfort
also showed a higher correlation (r = −0.49). The Child Health Questionnaire domain of
general health perceptions was correlated with many Congenital Heart Adolescent and
Teenage questionnaire domains, without a predominant pattern suggesting face validity.
Likewise, the Congenital Heart Adolescent and Teenage questionnaire domain of emotions
correlated with many Child Health Questionnaire domains, without a predominant pattern.
For the purposes of further analyses, the Child Health Questionnaire domain of physical
functioning was chosen to be contrasted against the Congenital Heart Adolescent and
Teenage questionnaire domain of activity limitations, and the Child Health Questionnaire
Cardiol Young. Author manuscript; available in PMC 2014 June 24.
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domain of freedom from bodily pain was chosen to be contrasted against the Congenital
Heart Adolescent and Teenage questionnaire domain of symptom discomfort.
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Associations with medical history and laboratory testing
Multi-variable linear regression analyses were performed for groups of variables, medical
history and laboratory testing, versus the dependent variable of each of the four chosen
domain scores (Table 3). For all four domains, the proportion of variation (adjusted R2) in
the scores explained by the medical history and laboratory testing variable sets was low;
however, it was highest for the Child Health Questionnaire physical functioning domain and
both medical history and exercise testing variable groups. Associations were weak for
echocardiography, magnetic resonance imaging, and brain natriuretic peptide level
variables.

Discussion
Summary
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Except for physical functioning, Fontan patients tended to score themselves better than
normal for many aspects of the functional health status. Equivalent conceptual domains
could be identified between the generic and disease-specific assessment. Exercise capacity
was the strongest factor associated with the physical aspects of the functional health status,
with stronger relationships to the generic versus the disease-specific measures. Medical
history and non-cardiac health problems also were associated with physical aspects but more
weakly and, again, with stronger relationships with the generic measure. Measures of
ventricular structure and function and brain natriuretic peptide were very weakly associated
with physical aspects of the functional health status. In contrast to our expectation, it would
appear that the physical domains of the disease-specific measure were less strongly
associated with medical history and laboratory testing than those from the generic measure.
Conceptualisation
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With the ongoing reduction in mortality and cardiovascular morbidity related to congenital
heart disease and its management, there has been a shift in focus towards other important
outcomes, particularly neurodevelopment and quality of life.12,13 However, present
literature on quality of life for congenital heart disease patients is limited by inconsistencies
in conceptualisation and definition.14 The terms quality of life, health-related quality of life,
and functional health status have been used interchangeably.15 Quality of life entails a
conceptualisation of an individual’s personal sense or perception on their well-being and
may include relative values such as satisfaction and enjoyment.16 Quality of life, therefore,
often means different things to different people, sometimes in intangible ways that makes a
strictly quantitative assessment difficult.14 Health-related quality of life defines the
component of quality of life that is influenced by health. The functional health status differs
in its conceptualisation in that it reflects an individual’s perceptions on their capacity and
participation in roles, behaviours, and activities of daily living. The functional health status
defines the impact of health issues on the functional status and is the primary concept being
assessed in the majority of reports purported to be studying quality of life in congenital heart
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disease patients. We have taken the Child Health Questionnaire and the Congenital Heart
Adolescent and Teenage questionnaire as measures of the functional health status.
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Perspective
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A critical appraisal of quality of life assessments in congenial heart disease highlighted the
lack of consistency in underlying constructs, the relevance of differing perspectives, and the
need to include a qualitative assessment.14 Perspective is important for paediatric
assessment, as young children may not be able to complete the assessments themselves;
hence, the need for proxy reporting, usually from parents. Providers, patients, and parents
can differ significantly in terms of the importance each attaches to different aspects of the
functional health status or quality of life.17 Previous studies have shown that Fontan patients
tend to perceive themselves as having a higher functional health status than participants
from normal control populations.3,11 They also score themselves higher than how their
parents would score them.5 In contrast, Fontan patients tend to perceive their functional
health status lower relative to their normal healthy siblings and patients with siblings rate
themselves lower than patients without siblings, indicating that self-perception may be
altered when the patient has a constant context for his or her own perception.6 Parents have
been reported to perceive deficits in their own health-related quality of life, which are
influenced by the clinical state of the patient.18
Comparison of generic and disease-specific assessments
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Several instruments have been developed to assess the health-related quality of life and
functional health status among children. The commonly used instruments include the Child
Health Questionniare,3 the Pediatric Quality of Life Inventory,19 the Toegepast
Natuurwetenschappelijk Onderzoek-Academisch Ziekenhuis Leiden (TNO-AZL) Child
Quality of Life Questionnaire,20,21 and the Health Utilities Index.22 The development and
use of instruments for assessment with specific disease populations has been advocated.
These instruments are developed with the goal of having a greater specificity with regard to
relationships with clinical aspects of the medical condition and a greater responsiveness to
change with clinical interventions. A cardiac-specific module has been developed for the
Pediatric Quality of Life Inventory.23,24 In addition, several congenital heart disease-specific
questionnaires have been developed de novo. For children, these include the Congenital
Heart Adolescent and Teenage questionnaire,9 the Pediatric Cardiac Quality of Life
Inventory,25 and the Congenital Heart Disease Quality of Life Questionnaire.26 For adults
with congenital heart disease, the Toegepast Natuurwetenschappelijk OnderzoekAcademisch Ziekenhuis Leiden Congenital Heart Disease Adult Quality of Life
Questionnaire has been used.27
Despite advocacy for disease-specific assessments, studies comparing generic and diseasespecific instruments have shown variable results in terms of associations with patient and
medical characteristics. This may, in part, reflect the differences in conceptualisation and
purpose, with greater or lesser overlap of domains, as well as differences in measurement
properties. No differences between generic and disease-specific assessments were observed
for the relationship with physical activity levels in patients with multiple sclerosis28 or in a
study of children with recurrent otitis media.29 Other studies have shown stronger
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measurement properties for disease-specific instruments. These include the higher
responsiveness observed in studies on patients undergoing cholecystectomy30 and on
patients with carpal tunnel syndrome.31 Greater internal consistency and dimensional
reproducibility with less factorial complexity and issues with floor and ceiling effects were
observed in a study of patients with heart failure.32 Some studies have shown that the
relationships have qualitative differences, being more highly associated with some
characteristics and outcomes than others, as observed in a study on patients with diabetes.33
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Uzark et al23,24 applied both the generic and cardiac module of the Pediatric Quality of Life
Inventory to children with congenital heart disease and observed high correlations between
specific domains for the two questionnaires; however, they did not compare associations
with disease severity or clinical characteristics. A recent work with the Pediatric Cardiac
Quality of Life Inventory involving a broad population of congenital heart disease patients
has shown that lower scores were observed for Fontan patients and for patients with
increased health care utilisation.34 The disease-specific scores also correlated with scores
from the generic assessment using the Pediatric Quality of Life Inventory. It has also been
shown that this instrument has external validity when used for children with cardiological
problems across multiple sites in the United States.35 Our study showed greater, although
weak, associations of patient and medical characteristics with the generic measure compared
with the disease-specific measure in a well-characterised population of Fontan patients.
Clearly, further research is required in this area.
Study limitations
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The results of this study should be interpreted in light of some potential limitations. The
patients involved may not be sufficiently representative of the total population of Fontan
patients and, likewise, the inability to achieve a uniform laboratory testing across the
patients may have also introduced a bias. The threshold at which clinical and laboratory
abnormalities have a measurable impact on the functional health status is unknown. The
suboptimal performance of the Congenital Heart Adolescent and Teenage questionnaire may
reflect deficiencies in this instrument rather than in disease-specific assessments in general.
For example, compared with the Pediatric Cardiac Quality of Life Inventory, the Congenital
Heart Adolescent and Teenage questionnaire is shorter, has less depth, and has had less
rigorous development and validation.35 Both questionnaires used may have unknown
limitations with regard to conceptualisation, scoring with floor and ceiling effects, validity,
reliability, and responsiveness, and they may also differ on these properties, particularly in
the chosen domains that were compared. Although both questionnaires have the advantage
of being completed by the patients themselves, the results reflect self-perceptions, are
necessarily subjective, and do not incorporate the individual’s qualitative, that is, openended narrative, assessment, which would highlight issues specific to that individual. The
clinical importance of observed differences in the domain scores in relation to the published
normal population is not known. Likewise, the clinical importance of observed differences
in association with similar domain scores between the generic and disease-specific
assessment is not known.
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In our cross-sectional study on Fontan patients, greater associations with patient and clinical
characteristics were observed for the generic Child Health Questionnaire compared with the
disease-specific Congenital Heart Adolescent and Teenage questionnaire for two
conceptually equivalent physical domains. Nonetheless, associations of these domains with
patient and clinical characteristics were weak. Other disease-specific instruments may be
more responsive to treatment-related changes and have greater implications for specific
interventions. In the absence of acute or severe cardiac-related morbidities, the impact of
Fontan physiology on the overall functional health status may be less than that presently
assumed. Further research should explore the conceptualisation of the functional health
status and quality of life and the discovery of social, behavioural, emotional, and
environmental determinants that may be targeted for novel interventions aimed at improving
the functional health status in this specific population.
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Selected patient, medical, and laboratory testing characteristics (n = 325).
Variable

n

Value*

Medical history (n = 56 variables, selected variables shown)
Age at enrolment (years)

325

13.6 (11.5, 16.0)

Male gender

325

193 (59%)

Ethnicity

325

White

270 (84%)

Black

32 (10%)

Asian

7 (2%)

Other

16 (5%)

Cardiac anatomy

325

Tricuspid atresia

80 (25%)

Hypoplastic left heart syndrome

58 (18%)

NIH-PA Author Manuscript

Double-inlet left ventricle

53 (16%)

Heterotaxia

22 (7%)

Mitral atresia

18 (5%)

Unbalanced atrioventricular septal defect

12 (4%)

Other single ventricle

76 (23%)

Age at Fontan procedure (years)

325

Fontan connection type

325

2.9 (2.2, 4.4)

Intracardiac lateral tunnel

196 (60%)

Atriopulmonary connection

70 (22%)

Extracardiac conduit

48 (15%)

Extracardiac lateral tunnel

1 (<%)

Other

10 (3%)

Years since Fontan procedure

325

Post-Fontan morbidities

325

10.5 (8.3, 12.4)

NIH-PA Author Manuscript

Arrhythmia

73 (23%)

Ventricular dysfunction

43 (13%)

Thrombosis

21 (7%)

Protein-losing enteropathy

12 (4%)

Stroke

9 (3%)

Current cardiac medication use

325

189 (58%)

Number of current cardiac medications

189

2 (1, 3)

309

13 (7, 29)

Laboratory testing
Brain natriuretic peptide (pg/ml)
Echocardiography (n = 16 variables, selected variables shown)
Ejection fraction (%)

245

58±11

Ejection fraction z-score

245

20.9±2.1

Ventricular end-diastolic volume (ml)

245

94±46

Ventricular end-diastolic volume z-score

245

20.7±1.9
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Ventricular mass (g)

n

Value*

240

110±52

Ventricular mass z-score

240

1.0±2.4

Ventricular mass/volume ratio (g/ml)

240

1.2±0.4

Ventricular mass/volume ratio z-score

240

2.8±3.3

Chronotropic index

289

0.6±0.2

Resting systemic oxygen saturation (%)

288

94±4

Cardiopulmonary exercise testing (n = 6 variables)

Percentage predicted peak oxygen consumption

287

63±15

Percentage predicted maximum work rate

288

62±17

Percentage predicted oxygen consumption at anaerobic threshold

245

76±22

Percentage predicted maximum oxygen pulse

287

87±22

109

72±23

Magnetic resonance imaging (n = 7 variables)
Total stroke volume (ml)
Total ejection fraction (%)

109

56±10

Total cardiac output (l/minute)

107

5.5±1.8

109

36±14

Total indexed end-systolic volume (ml/m2)
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(ml/m2)

109

81±21

Total indexed ventricular mass (g/m2)

109

70±20

Total mass/end-diastolic volume ratio (g/ml)

109

0.9±0.3

Total indexed end-diastolic volume

*

Values represent frequency (%), median (25th, 75th percentiles), or mean (±standard deviation)

NIH-PA Author Manuscript
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77±14
76±14
81±14
66±16
80±21

319
323
322
323
323
321

Behaviour

Mental health

Self-esteem

General health perceptions

308
294
281

Change in health
(five categories; 5 = much better now than 1 year ago to 1 = much worse now than 1 year ago)

Global health
(five categories; 100 = excellent to 0 = poor)

Global behaviour
(five categories; 100 = excellent to 0 = poor)

Cardiol Young. Author manuscript; available in PMC 2014 June 24.
320
315

Activity limitations

Career concerns

Perceived severity of heart condition

(1 = excellent to 5 = poor)

315

321

General health

22±18

318

Emotional concerns

Symptom discomfort

2.1±0.9

16±17

15±16

6±6

7±15

79±22

77±19

3.8±0.9

72±24

91±18

321

Friendship problems

Congenital Heart Adolescent Teenage questionnaire –
scale domains

314

Family cohesion
(five categories; 100 = xcellent to 0 = poor)

Child Health Questionnaire – single-item domains

Family activities

79±22

322

Role/social limits – behavioural

Bodily pain

91±18
88±20

318
324

Role/social limits – physical

87±13

Mean±standard
deviation

323

n

Role/social limits – emotional

Physical functioning

Child Health Questionnaire – scale domains

Questionnaire and domain

NIH-PA Author Manuscript

Domain scores for functional health status.

2 (1, 3)

10 (5, 25)

13 (4, 21)

5 (2, 8)

19 (6, 31)

0 (0, 8)

85 (60, 100)

85 (60, 100)

4 (3, 5)

85 (60, 85)

88 (67, 100)

68 (55, 78)

82 (71, 91)

77 (69, 86)

79 (68, 87)

80 (70, 100)

100 (89, 100)

100 (83, 100)

100 (89, 100)

89 (81, 96)

Median (25th, 75th
percentiles)

Not available

Not available

Not available

Not available

Not available

Not available

Not available

Not available

Not available

Not available

Not available

66±15

82±16

73±16

77±15

74±23

87±22

86±21

88±21

89±14

Published
norms

0.73

0.92

<0.001

0.22

<0.001

<0.001

<0.001

<.001

0.05

p-value*
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(0 = not at all serious to 5 = very serious)

312

2.5±1.4

3 (1, 3)

Median (25th, 75th
percentiles)

Wilcoxon signed-rank test was used to compare the distribution of the CHQ scores from the study with the values for a normal population

*

CHQ=Child Health Questionnaire

Social life affected by heart condition

Mean±standard
deviation

NIH-PA Author Manuscript
n
Not available

Published
norms
p-value*
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CHAT activity limitations
CHQ bodily pain scale
CHAT symptom discomfort

Brain natriuretic peptide**

Brain natriuretic peptide**

Brain natriuretic peptide**

Brain natriuretic peptide**
0.01

0.01

0.01

0.00

0.08

0.10

0.11

0.07

0.04

0.10

0.08

0.08

0.01

0.01

0.00

0.00

0.02

0.03

0.04

0.01

0.00

0.03

0.02

0.01

0.01

0.00

0.06

0.22

0.09

0.15

0.12

0.14

R2 adjusted

After normalizing logarithmic transformation

After normalizing rank transformation

**

*

CHQ = Child Health Questionnaire; CHAT = Congenital Heart Adolescent and Teenage

CHAT symptom discomfort
CHQ physical functioning scale

Magnetic resonance imaging

CHAT activity limitations
CHQ bodily pain scale

Magnetic resonance imaging

Magnetic resonance imaging

CHAT symptom discomfort
CHQ physical functioning scale

Magnetic resonance imaging

CHQ bodily pain scale

Echocardiography

Echocardiography

CHAT activity limitations

Echocardiography

0.07

CHAT symptom discomfort
CHQ physical functioning scale

Exercise testing

Echocardiography

0.02

CHQ bodily pain scale

0.11

CHAT activity limitations

Exercise testing

0.26

Exercise testing

CHAT symptom discomfort
CHQ physical functioning scale

Medical history

0.30

0.27

0.29

R2

Exercise testing

CHAT activity limitations
CHQ bodily pain scale

Medical history

CHQ physical functioning scale

Medical history

Medical history

Dependent

Test (group of predictors)

1

1

1

1

7

7

7

7

16

16

16

16

6

6

6

6

56

56

56

56

n variables

305

304

304

307

106

105

107

107

242

240

240

243

114

116

115

115

322

319

320

323

n observations

Full model regression analyses for variable categories for equivalent conceptual domains from the self-report CHQ and the CHAT Questionnaire*.
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